Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.68 USD | +0.98% | +3.48% | -11.03% |
09/04 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
09/04 | Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study | MT |
Sales 2024 * | 1.52B 127B | Sales 2025 * | 1.52B 127B | Capitalization | 4.18B 348B |
---|---|---|---|---|---|
Net income 2024 * | 352M 29.35B | Net income 2025 * | 331M 27.6B | EV / Sales 2024 * | 2.23 x |
Net cash position 2024 * | 791M 65.93B | Net cash position 2025 * | 1.17B 97.59B | EV / Sales 2025 * | 1.97 x |
P/E ratio 2024 * |
12.1
x | P/E ratio 2025 * |
13.4
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.59% |
Latest transcript on Alkermes plc
1 day | +0.98% | ||
1 week | +3.48% | ||
Current month | -8.83% | ||
1 month | -9.43% | ||
3 months | -11.03% | ||
6 months | +3.26% | ||
Current year | -11.03% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 01/91/01 |
Blair Jackson
DFI | Director of Finance/CFO | 51 | 01/99/01 |
Shane Cooke
PSD | President | 61 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 01/91/01 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 26/16/26 |
Brian McKeon
BRD | Director/Board Member | 61 | 10/20/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.32% | 215 M€ | +10.68% | - | |
2.65% | 1 M€ | -5.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 24.68 | +0.98% | 1,016,741 |
25/24/25 | 24.44 | -0.85% | 1,313,771 |
24/24/24 | 24.65 | +1.61% | 1,737,019 |
23/24/23 | 24.26 | +0.79% | 1,245,764 |
22/24/22 | 24.07 | +0.92% | 1,708,265 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.03% | 4.18B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALKS Stock